{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T04:10:29Z","timestamp":1751688629494,"version":"3.41.0"},"reference-count":36,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"4","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:p>Background: Meniere's disease (MD) is a prevalent condition in otolaryngology, with its annual incidence rate increasing. Consequently, understanding the underlying mechanisms of MD is of significant importance. The aim is to investigate the relationship between serum levels of interleukin-1b (IL-1b) and interleukin-18 (IL-18), as well as the activation status of NLRP6 inflammasomes, in patients with Meniere's disease and to evaluate their correlation with the severity of the disease, to improve the treatment strategy of Meniere's disease. Methods: From March 2021 to December 2023, 75 MD patients were selected from the Affiliated Huaian No.1 People's Hospital of Nanjing Medical University for research, and a control group consisting of 75 age-matched healthy individuals was established. Each participant contributed a 5 mL peripheral venous blood sample, which was archived at -80 \u00b0C for subsequent analyses. The expression levels of NLRP6 messenger RNA in the blood samples were quantified using real-time fluorescence quantitative PCR methodology. Concentrations of interleukin-1b (IL-1b) and interleukin-18 (IL-18) were measured via enzyme-linked immunosorbent assay (ELISA). Through a comparative examination of NLRP6, IL-1b, and IL-18 levels between MD patients and the healthy controls, the study delved into the potential association between NLRP6 expression and the circulating levels of these two cytokines. In addition, special attention is paid to the differences between unilateral and bilateral MD patients in the above three indexes to evaluate their effectiveness as potential biomarkers for predicting the severity of hearing loss in MD patients. Results: In individuals suffering from MD, a notable elevation was observed in the peripheral blood expression levels of NLRP6, IL-1b, and IL-18 (p&lt;0.001). A correlation assessment disclosed a positive association between the blood NLRP6 content and both IL-1b and IL-18 concentrations among these patients. Notably, no substantial disparity emerged in the expression profiles of these three biomarkers when comparing unilateral versus bilateral MD cases (p&gt;0.05). Furthermore, patients at advanced stages (III+IV) exhibited significantly heightened levels of NLRP6, IL-1b, and IL-18 compared to their counterparts in earlier stages (I+II) (p&lt;0.001). Receiver operating characteristic (ROC) curve analyses demonstrated that the area under the curve (AUC) for NLRP6, IL-1b, and IL-18 stood at 0.8731, 0.8089, and 0.7838, respectively, suggesting their potential as proficient diagnostic markers capable of differentiating MD patients from healthy controls. Conclusions: NLRP6, IL-1b, and IL-18 are highly expressed in the peripheral blood of MD patients. NLRP6, IL-1b, and IL-18 can serve as early diagnostic indicators for MD.<\/jats:p>","DOI":"10.5937\/jomb0-55001","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T08:08:56Z","timestamp":1742198936000},"page":"740-747","source":"Crossref","is-referenced-by-count":0,"title":["Correlation between NLRP6 inflammasome and the levels of inflammatory cytokines IL-1b and IL-18 in serum of patients with Meniere's disease"],"prefix":"10.5937","volume":"44","author":[{"given":"Mengxiao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhibiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3964","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Hoskin JL, M\u00e9ni\u00e8re's disease: new guidelines, subtypes, imaging, and more. Current Opinion in Neurology 2022; 35: 90-7, doi: 10.1097\/wco.0000000000001021;","DOI":"10.1097\/WCO.0000000000001021"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Gibson WPR, M\u00e9ni\u00e8re's disease. Advances in Otorhinolaryngology 2019; 82: 77-86, doi:10.1159\/000490274;","DOI":"10.1159\/000490274"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Lopez-Escamez JA, Liu Y, Epidemiology and genetics of M\u00e9ni\u00e8re's disease. Current Opinion in Neurology 2024; 37: 88-94, doi: 10.1097\/wco.0000000000001227;","DOI":"10.1097\/WCO.0000000000001227"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Xu W, Li X, Song Y, Kong L, Zhang N, Liu J, Li G, Fan Z, Lyu Y , Zhang D, et al. M\u00e9ni\u00e8re's disease and allergy: epidemiology, pathogenesis, and therapy. Clinical and Experimental Medicine 2023; 23: 3361-71, doi: 10.1007\/ s10238-023-01192-0;","DOI":"10.1007\/s10238-023-01192-0"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Ahmad JG, Lin KF , M\u00e9ni\u00e8re's disease is a disorder of the inner ear. Current Opinion in Otolaryngology & Head and Neck Surgery 2023; 31: 320-4, doi: 10.1097\/ moo. 0000000000000921;","DOI":"10.1097\/MOO.0000000000000921"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Espinosa-Sanchez JM, Lopez-Escamez JA, M\u00e9ni\u00e8re's disease. Handbook of Clinical Neurology 2016; 137: 257-77, doi: 10.1016\/b978-0-444-63437-5.00019-4;","DOI":"10.1016\/B978-0-444-63437-5.00019-4"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Cooper MW, Kaylie DM, Is endolymphatic sac surgery beneficial for M\u00e9ni\u00e8re's disease? The Laryngoscope 2020; 130: 2738-9, doi: 10.1002\/lary.28647;","DOI":"10.1002\/lary.28647"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Sood AJ, Lambert PR, Nguyen SA, Meyer TA, Endolymphatic sac surgery for M\u00e9ni\u00e8re's disease: a systematic review and meta-analysis. Otology & neurotology: official publication of the American Otological Society, American Neurotology Society (and) European Academy of Otology and Neurotology 2014; 35: 1033-45, doi: 10.1097\/ mao.0000000000000324;","DOI":"10.1097\/MAO.0000000000000324"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Kim SH, Kim JY, Lee HJ, Gi M, Kim BG, Choi JY, Autoimmunity as a candidate for the etiopathogenesis of M\u00e9ni\u00e8re's disease: detection of autoimmune reactions and diagnostic biomarker candidate. PloS One 2014; 9: e111039, doi: 10.1371\/journal.pone.0111039;","DOI":"10.1371\/journal.pone.0111039"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Mwangi M, Kil SH, Phak D, Park HY, Lim DJ, Park R, Moon SK, Interleukin-10 attenuates hypochlorous acid-mediated cytotoxicity to HEI-OC1 cochlear cells. Frontiers in Cellular Neuroscience 2017; 11: 314, doi: 10.3389\/fncel.2017.00314;","DOI":"10.3389\/fncel.2017.00314"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Simoni E, Gentilin E, Candito M, Borile G, Romanato F , Chicca M, Nordio S, Aspidistria M, Martini A, Cazzador D, et al. Immune response after cochlear implantation. Frontiers in Neurology 2020; 11: 341, doi: 10.3389\/ fneur.2020.00341;","DOI":"10.3389\/fneur.2020.00341"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Vethanayagam RR, Yang W, Dong Y, Hu BH, Toll-like receptor 4 modulates the cochlear immune response to acoustic injury. Cell Death & Disease 2016; 7: e2245, doi: 10.1038\/cddis.2016.156;","DOI":"10.1038\/cddis.2016.156"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Dai Q, Long L, Zhao H, Wang R, Zheng H, Duan M, Genetic advances in M\u00e9ni\u00e8re's disease. Molecular Biology Reports 2023; 50: 2901-8, doi: 10.1007\/s11033-022-08149-8;","DOI":"10.1007\/s11033-022-08149-8"},{"key":"ref14","unstructured":"Yoshino K, Ohashi T , Urushibata T , Kenmochi M, Akagi M, Antibodies of type II collagen and immune complexes in M\u00e9ni\u00e8re's disease. Acta Otolaryngologica. Supplementum 1996; 522: 79-85;"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Rauch SD, Zurakowski D, Bloch DB, Bloch KJ, Anti-heat shock protein 70 antibodies in M\u00e9ni\u00e8re's disease. The Laryngoscope 2000; 110: 1516-21, doi: 10.1097\/00005537-200009000-00020;","DOI":"10.1097\/00005537-200009000-00020"},{"key":"ref16","unstructured":"Rauch SD, San Martin JE, Moscicki RA, Bloch KJ, Serum antibodies against heat shock protein 70 in M\u00e9ni\u00e8re's disease. The American Journal of Otology 1995; 16: 648-52;"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Ruckenstein MJ, Prasthoffer A, Bigelow DC, Von Feldt JM, Kolasinski SL, Immunologic and serologic testing in patients with M\u00e9ni\u00e8re's disease. Otology & neurotology: official publication of the American Otological Society, American Neurotology Society (and) European Academy of Otology and Neurotology 2002; 23: 517-20; discussion 520-511, doi: 10.1097\/00129492-200207000-00021;","DOI":"10.1097\/00129492-200207000-00021"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Flook M, Rojano E, Gallego-Martinez A, Escalera-Balsera A, Perez-Carpena P , Moleon MDC, Gonzalez-Aguado R, Rivero de Jesus V, Dom\u00ednguez-Dur\u00e1n E, Frejo L, et al. Cytokine profiling and transcriptomics in mononuclear cells define immune variants in M\u00e9ni\u00e8re's disease. Genes and Immunity 2024; 25: 124-31, doi: 10.1038\/s41435-024-00260-z;","DOI":"10.1038\/s41435-024-00260-z"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Zhang S, Gong Y, Liang Y, Wang B, Gao W, Xu Q, Cyclophosphamide inhibits the progression of M\u00e9ni\u00e8re's disease by reducing the generation of circulating immune complex. Experimental and therapeutic medicine 2021; 22: 1177, doi: 10.3892\/etm.2021.10611;","DOI":"10.3892\/etm.2021.10611"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Chan KC, Wu CM, Ho WL, Lai PC, Association of M\u00e9ni\u00e8re's disease with human leukocyte antigen in Taiwanese population. Ear, Nose, & Throat Journal 2018; 97: 396-402, doi: 10.1177\/014556131809701208;","DOI":"10.1177\/014556131809701208"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Pathak S, Vambutas A, NaCl exposure results in increased expression and processing of IL-1 in M\u00e9ni\u00e8re's disease patients. Scientific reports 2022; 12: 4957, doi: 10.1038\/s41598-022-08967-7;","DOI":"10.1038\/s41598-022-08967-7"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Kouhi A, Shakeri S, Yazdani N, Shababi N, Mohseni A, Mohseni A, Sadr M, Mohammad Amoli M, Rezaei A, Rezaei N, Association of proinflammatory cytokine gene polymorphism with M\u00e9ni\u00e8re's disease in an Iranian sample. Iranian Journal of Allergy, Asthma, and Immunology 2021; 20: 734-9, doi: 10.18502\/ijaai.v20i6.8024;","DOI":"10.18502\/ijaai.v20i6.8024"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Requena T, Gazquez I, Moreno A, Batuecas A, Aran I, Soto-Varela A, Santos-Perez S, Perez N, Perez-Garrigues H, Lopez-Nevot A, et al. Allelic variants in TLR10 gene may influence bilateral affectation and clinical course of M\u00e9ni\u00e8re's disease. Immunogenetics 2013; 65: 345-55, doi: 10.1007\/s00251-013-0683-z;","DOI":"10.1007\/s00251-013-0683-z"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Zhang S, Guo Z, Tian E, Liu D, Wang J, Kong W, M\u00e9ni\u00e8re's disease subtyping: the direction of diagnosis and treatment in the future. Expert Review of Neurotherapeutics 2022; 22: 115-27, doi: 10.1080\/14737175.2022.2030221;","DOI":"10.1080\/14737175.2022.2030221"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Basura GJ, Adams ME, Monfared A, Schwartz SR, Antonelli PJ, Burkard R, Bush ML, Bykowski J, Colandrea M, Derebery J, et al. Clinical practice guideline: M\u00e9ni\u00e8re's disease executive summary. Otolaryngology-head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery 2020; 162: 415-34, doi: 10.1177\/0194599820909439;","DOI":"10.1177\/0194599820909439"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Couto D, Zipfel C, Regulation of pattern recognition receptor signalling in plants. Nature reviews. Immunology 2016; 16: 537-52, doi: 10.1038\/nri.2016.77;","DOI":"10.1038\/nri.2016.77"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Rathinam VA, Fitzgerald KA, Inflammasome complexes: emerging mechanisms and effector functions. Cell 2016; 165: 792-800, doi: 10.1016\/j.cell.2016.03.046;","DOI":"10.1016\/j.cell.2016.03.046"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"de Carvalho Ribeiro M, Szabo G, Role of the inflammasome in liver disease. Annual review of pathology 2022; 17: 345-65, doi: 10.1146\/annurev-pathmechdis-032521-102529;","DOI":"10.1146\/annurev-pathmechdis-032521-102529"},{"key":"ref29","unstructured":"Wagener M, Laskas JW, Purcell S, Ermolovich T , Muckle-Wells syndrome in the setting of basal cell nevus syndrome. Cutis 2017; 99: 421-4;"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Frejo L, Lopez-Escamez JA, Cytokines and inflammation in M\u00e9ni\u00e8re's disease. Clinical and Experimental Oto-rhino laryngology 2022; 15: 49-59, doi: 10.21053\/ceo.2021.00920;","DOI":"10.21053\/ceo.2021.00920"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Hara H, Seregin SS, Yang D, Fukase K, Chamaillard M, Alnemri ES, Inohara N, Chen GY , N\u00fa\u00f1ez G, The NLRP6 inflammasome recognises lipoteichoic acid and regulates Gram-positive pathogen infection. Cell 2018; 175: 1651-64. e1614, doi: 10.1016\/j.cell.2018.09.047;","DOI":"10.1016\/j.cell.2018.09.047"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Ghimire L, Paudel S, Jin L, Jeyaseelan S, The NLRP6 inflammasome in health and disease. Mucosal Immunology 2020; 13: 388-98, doi: 10.1038\/s41385-020-0256-z;","DOI":"10.1038\/s41385-020-0256-z"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Cai S, Paudel S, Jin L, Ghimire L, Taylor CM, Wakamatsu N, Bhattarai D, Jeyaseelan S, NLRP6 modulates neutrophil homeostasis in bacterial pneumonia-derived sepsis. Mucosal Immunology 2021; 14: 574-84, doi: 10.1038\/s41385-020-00357-4;","DOI":"10.1038\/s41385-020-00357-4"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Xiao H, Chen H, Jiang R, Zhang L, Wang L, Gan H, Jiang N, Zhao J, Zhai X, Liang P , NLRP6 contributes to inflammation and brain injury following intracerebral haemorrhage by activating autophagy. Journal of Molecular Medicine (Berlin, Germany) 2020; 98: 1319-31, doi: 10.1007\/s00109-020-01962-3;","DOI":"10.1007\/s00109-020-01962-3"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Mahmutovic Persson I, Menzel M, Ramu S, Cerps S, Akbarshahi H, Uller L, IL-1 mediates lung neutrophilia and IL-33 expression in a mouse model of viral-induced asthma exacerbation. Respiratory Research 2018; 19: 16, doi: 10.1186\/s12931-018-0725-z;","DOI":"10.1186\/s12931-018-0725-z"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Yasuda K, Nakanishi K, Tsutsui H, Interleukin-18 in health and disease. International Journal of Molecular Sciences 2019; 20: doi: 10.3390\/ijms20030649;","DOI":"10.3390\/ijms20030649"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Korelacija izme\u0111u NLRP6 inflamazoma i nivoa inflamatornih citokina IL-1b i IL-18 u serumu pacijenata sa Menierovom bole\u0161\u0107u"],"language":"en","link":[{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2025\/1452-82582504740L.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T14:50:56Z","timestamp":1751640656000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582504740L"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-55001","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"type":"print","value":"1452-8258"},{"type":"electronic","value":"1452-8266"}],"subject":[],"published":{"date-parts":[[2025]]}}}